Skip to main content

Table 1 Characteristics and profiles of patients

From: Predictors and clinical outcomes of post-coronary artery bypass grafting cerebrovascular strokes

Variables

All patients (410)

Stroke group (31,7.5%)

Non-stroke group (379,92.5%)

P value

Age (years)

60 (55–68)

66 (54–75)

60 (55–68)

0.06

Gender, male (n, %)

337 (82.2)

19 (61.3)

318 (83.9)

0.002

BMI (kg/m2)

28.05 (25.8–31.8)

28 (25–31.8)

28.1 (25.6–31.8)

0.88

Smoking (n, %)

159 (38.8)

11 (35.5)

148 (39.1)

0.69

Diabetes mellitus (n, %)

338 (82.4)

23 (74.5)

315 (83.1)

0.209

Hyperlipidemia (n, %)

245 (59.8)

19 (61.3)

226 (59.6)

0.85

Chronic Kidney disease (n, %)

117 (28.5)

12 (38.7)

105 (27.7)

0.041

Hypertension (n, %)

351 (85.6)

25 (80.6)

326 (86)

0.42

Bronchial asthma (n, %)

44 (10.7)

5 (16.1)

39 (10.3)

0.359

Hypothyroidism (n, %)

42 (10.2)

3 (9.7)

39 (10.3)

1

Hyperthyroidism (n, %)

3 (0.7)

0 (0)

3 (0.8)

1

Preoperative AF (n, %)

26 (6.3)

2 (6.5)

24 (6.3)

1

Malignancy (n, %)

26 (6.3)

2 (6.5)

24 (6.3)

1

Renal/liver transplant (n, %)

17 (4.1)

1 (3.2)

16 (4.2)

1

Prior stroke (n, %)

28 (6.8)

6 (19.4)

22 (5.8)

0.013

Prior TIAs (n, %)

24 (5.9)

3 (9.7)

21 (5.5)

0.41

Carotid artery stenosis (n, %)

37 (9)

10 (32.3)

27 (7.1)

 < 0.001

Peripheral vascular disease (n, %)

44 (10.7)

3 (9.7)

41 (10.8)

1

Prior myocardial infarction (n, %)

257 (62.7)

24 (77.4)

233 (61.5)

0.07

Prior PCI (n, %)

137 (33.4)

10 (32.3)

127 (33.5)

0.88

Prior cardiac surgeries

27 (6.6)

7 (22.6)

20 (5.3)

0.002

Preoperative LVEF% (n, %)

More than 55%

141 (34.4)

10 (32.3)

131 (34.6)

0.052

45–55%

106 (25.9)

4 (12.9)

102 (26.9)

35–45

88 (21.5)

6(19.4)

82 (21.6)

Less than 35%

75 (18.3)

11 (35.5)

64 (16.9)

Preoperative drugs (n, %)

Beta-blockers

321 (78.3)

18 (58.1)

303 (79.9)

0.004

Statins

343 (83.7)

21 (67.7)

322 (85)

0.013

Fibrates

45 (11)

2 (6.5)

43 (11.3)

0.55

ACEI/ARBs

187 (45.6)

10 (32.3)

177 (46.7)

0.12

Steroids

18 (4.4)

1 (3.2)

17 (4.5)

1

Immune suppression

11 (2.7)

1 (3.2)

10 (2.6)

0.58

Preoperative IABP (n, %)

15 (3.7)

3 (9.7)

12 (3.2)

0.09

Preoperative ECMO (n, %)

2 (0.5)

2 (6.5)

0 (0)

0.006

  1. BMI body mass index, AF atrial fibrillation, CAS carotid artery stenosis, PCI percutaneous coronary intervention, ACEI angiotensin-converting enzyme inhibitors, IABP intra-aortic balloon pump, LVEF left ventricle ejection fraction, TIAs transient ischemic attacks, ARBs angiotensin receptor blockers, ECMO extracorporeal membrane oxygenation